Anirban Sen Gupta on Biosynthetic Blood Surrogates Current State-of-Art
Anirban Sen Gupta, Wallace R. Persons Professor of Engineering in the Department of Biomedical Engineering at Case Western Reserve University, shared on LinkedIn:
”Excited to share a labor of love from my lab….a historical perspective and comprehensive review of biomaterials-based approaches in the engineering of biosynthetic blood surrogates.
We discuss the challenges and opportunities, failures and successes, spanning four decades of research, and highlight the current State-of-Art, emphasizing how such technologies could potentially enable national and global health equity in transfusion medicine.
Great teamwork by Dante Disharoon, Sonali Rohiwal, Bipin Chakravarthy Paruchuri, Selvin Hernandez, Norman Luc, Rohini Sekar at Case Western Reserve University Department of Biomedical Engineering in getting this wrapped up!
Grateful to Elizabeth Nance for the opportunity to consider this for BioTM.”
Read the full article here.
Article: Biosynthetic blood surrogates: Current status and future opportunities
Authors: Dante Disharoon, Sonali Rohiwal, Selvin Hernandez, Bipin Chakravarthy Paruchuri, Rohini Sekar, Norman Luc, Anirban Sen Gupta

Stay updated on all scientific advances with Hemostasis Today.
-
Oct 26, 2025, 16:55ECTH 2025: 3 Unforgettable Days of Science and Shared Purpose
-
Oct 26, 2025, 16:35Ahmed Koriesh on Thrombolysis in Stroke Patients on DOACs
-
Oct 26, 2025, 15:39Lisa Murphy on Life After Stroke Sessions at WSC 2025
-
Oct 26, 2025, 15:21Patricia Simal Presented the Spanish National Health System's Stroke Strategy at WSC 2025
-
Oct 26, 2025, 14:32Paula Boldo on Sex-Stratified Genetic Risk of Stroke at WSC 2025
-
Oct 26, 2025, 15:04Nita Radhakrishnan and Colleagues on Inherited Haematological Conditions
-
Oct 26, 2025, 14:55Anirban Sen Gupta on Biosynthetic Blood Surrogates Current State-of-Art
-
Oct 26, 2025, 12:24Jean Philippe Galanaud, Jean Pierre Laroch, and Marc Righini on Historical Treatments of DVT
-
Oct 24, 2025, 12:08Julián Alejandro Rivillas Compares Tenecteplase to Low-dose Alteplase: TRACE-5 Interim Phase II Results
-
Oct 24, 2025, 12:03Melissa Glasner on Integration of Gene Therapy Into Hemophilia Care
-
Oct 23, 2025, 09:57Arun V. J: Artificial Blood Is Closer Than You Think
-
Oct 23, 2025, 07:11Sebastien Lobet Presented the ACTIVLIM-Hemo Scale
-
Oct 23, 2025, 07:05Syed Ehsan Shah on Advantages of Werfen HemoCell Automation
-
Oct 22, 2025, 08:25Johanna Nystedt: Not Every Day We Can Release a New Blood Product to Meet An Unmet Medical Need!
-
Oct 21, 2025, 06:58Arno Nierich: How Caffeine Affects Red Blood Cells and Blood Storage
-
Oct 25, 2025, 09:32Sylaja Pn Wins 2025 WSO Presidential Award
-
Oct 25, 2025, 08:21Courtney Lawrence: Listen. Empower. Deliver. Save Lives!
-
Oct 25, 2025, 08:14Hema Tallman on Incredible Opportunity to Participate in the PPTA 2025 Meetings
-
Oct 24, 2025, 11:28Louise Bannon and Thomas Reiser Thank World Thrombosis Day Supporters Around The World
-
Oct 24, 2025, 10:48Melanie Daniel Congratulates Mickael Rosa and Antoine Rauch on Winning Bernd R. Binder Prize
